Literature DB >> 19643938

Toll-like receptor 7 function is reduced in adolescents with asthma.

M Roponen1, S T Yerkovich, E Hollams, P D Sly, P G Holt, J W Upham.   

Abstract

Anti-viral innate immune responses may be impaired in asthma, although the mechanisms are not well understood. Toll-like receptors (TLRs) 7 and 3 are particularly relevant for initiating responses to common respiratory viruses, as they recognise single-stranded viral RNA and double-stranded viral RNA, respectively. The aim of the present study was to investigate TLR7 and TLR3 function in 14-yr-old adolescents with asthma. Blood mononuclear cells obtained from 17 atopic asthmatics, 29 atopic, non-asthmatics and 21 healthy, non-atopic individuals, were stimulated with the TLR7 agonist imiquimod and the TLR3 agonist poly I:C. Expression of anti-viral molecules was measured by real-time PCR. Concentrations of interferon-gamma-inducible cytokine protein (IP)-10 and interleukin (IL)-6 were measured by ELISA. TLR7-induced myxovirus resistance protein A and 2'5' oligoadenylate synthetase mRNA expression and protein levels of IP-10 were significantly lower in asthma subjects compared with healthy subjects (p = 0.041, p = 0.003 and p = 0.001 respectively). There was a significant negative correlation between total serum immunoglobulin E and IP-10 following TLR7 stimulation. However, TLR3-induced responses did not vary with asthma or atopy. IL-10 mRNA and IL-6 protein synthesis were similar in asthmatic and control subjects. In conclusion, TLR7 function is reduced in adolescents with asthma and this may contribute to susceptibility to respiratory viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643938     DOI: 10.1183/09031936.00172008

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

1.  Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab.

Authors:  Michelle A Gill; Andrew H Liu; Agustin Calatroni; Rebecca Z Krouse; Baomei Shao; Allison Schiltz; James E Gern; Alkis Togias; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2017-09-01       Impact factor: 10.793

2.  Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs.

Authors:  Elad H Kaufman; Allison D Fryer; David B Jacoby
Journal:  J Allergy Clin Immunol       Date:  2010-12-17       Impact factor: 10.793

Review 3.  Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.

Authors:  Damir Matesic; Aleksander Lenert; Petar Lenert
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 4.  Interferon at the crossroads of allergy and viral infections.

Authors:  Sarah R Gonzales-van Horn; J David Farrar
Journal:  J Leukoc Biol       Date:  2015-05-29       Impact factor: 4.962

5.  Lessons learned in the analysis of high-dimensional data in vaccinomics.

Authors:  Ann L Oberg; Brett A McKinney; Daniel J Schaid; V Shane Pankratz; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2015-05-06       Impact factor: 3.641

Review 6.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

Review 7.  The therapeutic potential of Toll-like receptor 7 stimulation in asthma.

Authors:  Matthew G Drake; Elad H Kaufman; Allison D Fryer; David B Jacoby
Journal:  Inflamm Allergy Drug Targets       Date:  2012-12

8.  Toll-like receptor 7 rapidly relaxes human airways.

Authors:  Matthew G Drake; Gregory D Scott; Becky J Proskocil; Allison D Fryer; David B Jacoby; Elad H Kaufman
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

9.  Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile.

Authors:  Hitasha Rupani; Rocio T Martinez-Nunez; Patrick Dennison; Laurie C K Lau; Nivenka Jayasekera; Tom Havelock; Ana S Francisco-Garcia; Christopher Grainge; Peter H Howarth; Tilman Sanchez-Elsner
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

10.  IFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma?

Authors:  Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.